Showing results (21-30 of 178) with videos related to
Sort By:
Pageof 18
Nuklearmedizin. Nuclear Medicine|April 21, 1998
[Optimization of PET image quality by means of 3D data acquisition and iterative image reconstruction]J Doll, J Zaers, H Trojan, et al.Medical Physics|May 5, 1999
Noninvasive determination of the arterial input function of an anticancer drug from dynamic PET scans using the population approachJ Kissel, R E Port, J Zaers, et al.Brain Research. Cognitive Brain Research|October 1, 1996
Functional MR imaging of semantic information processing and learning-related effects using psychometrically controlled stimulation paradigmsM Spitzer, M E Bellemann, T Kammer, et al.Nuklearmedizin. Nuclear Medicine|October 1, 1994
Functional MR mapping of activated cortical areasG Brix, F Gückel, M E Bellemann, et al.Fortschritte Der Neurologie-Psychiatrie|July 24, 1998
[Functional magnetic resonance tomography in psychopathological research]M Spitzer, T Kammer, M E Bellemann, et al.Brain Research. Cognitive Brain Research|June 19, 1998
Functional magnetic resonance imaging of category-specific cortical activation: evidence for semantic mapsM Spitzer, U Kischka, F Gückel, et al.Gene Therapy|November 14, 1998
Uncoupling of 2-fluoro-2-deoxyglucose transport and phosphorylation in rat hepatoma during gene therapy with HSV thymidine kinaseU Haberkorn, M E Bellemann, L Gerlach, et al.Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 3, 2001
Quantification of [(18)F]FDG uptake in the normal liver using dynamic PET: impact and modeling of the dual hepatic blood supplyG Brix, S I Ziegler, M E Bellemann, et al.Cancer Research|August 15, 1997
Pharmacokinetic analysis of 5-[18F]fluorouracil tissue concentrations measured with positron emission tomography in patients with liver metastases from colorectal adenocarcinomaJ Kissel, G Brix, M E Bellemann, et al.European Journal of Nuclear Medicine|May 19, 2001
Apoptosis and changes in glucose transport early after treatment of Morris hepatoma with gemcitabineU Haberkorn, M E Bellemann, G Brix, et al.Pageof 18